Historical data from the biotech sector appear to refute Fed Chair Janet Yellen’s remarks about stock valuations, ISI Group’s Mark Schoenbaum says.
Historical data from the biotech sector appear to refute Fed Chair Janet Yellen’s remarks about stock valuations, ISI Group’s Mark Schoenbaum says.